Looking to publish in Pulmonary Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowPulmonary Therapy is an international, open access, peer-reviewed single-blind rapid publication journal covering pulmonary therapies, devices, and surgical techniques. It publishes scientifically sound research across clinical, real-world, and health economics outcomes studies, welcomes digital features and plain language summaries, and offers a broad range of article types including podcast articles, Patient/Physician Perspective articles, and Summary of Research Articles.
Looking to publish in Pulmonary Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Pulmonary Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Brief Reports
Case Series
Case Reports
Guidelines
Letters To The Editor
Recent Publications
Impact of Single-Inhaler Triple Therapy FF/UMEC/VI on Disease Stability in COPD: A Real-World 12-Month Analysis
Chiara Lupia, Daniela Pastore, Antonio Giacalone, Federica Marrelli, Lucia Novelli, Debbie Riccelli, Angelantonio Maglio, Giuseppe Armentaro, Angela Sciacqua, Alessandro Vatrella, Girolamo Pelaia, Corrado Pelaia
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study
Bernardino Alcázar-Navarrete, Juan Marco Figueira-Gonçalves, Nagore Blanco Cid, Nuria Bruguera Avila, Roberto Bernabeu Mora, Antonia Fuster Gomila, Raúl Galera Martínez, Marta M. García Clemente, Galo Granados, Hassan Khadour Khadour, Eduardo Márquez-Martín, Igor Murga Arizabaleta, Jose Luis Velasco Garrido, Carmen Corregidor-García, Eunice Fitas, Joaquín Sánchez-Covisa
Peripheral Blood Inflammatory Markers and Immune Cell Profiles in Smokers With and Without COPD
Wenying Lu, Maddison Waters, Josie Larby, Sapha Shibeeb, Steven Bozinovski, Stavros Selemidis, Jonathan McQualter, Ross Vlahos, Md Imtaiyaz Hassan, Heinrich Weber, Sukhwinder Singh Sohal
Patient Characteristics and Healthcare Resource Use among Patients With COVID-19 Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID™) in the Kingdom of Saudi Arabia
Basem M. Alraddadi, Reem S. Almaghrabi, Mohammad Bosaeed, Mohamed Kamal, Ashraf Hassanien, Haridy Hammam, Giovanni Zanotti, Burcu Karakuzu Ikizler, Florence Lefebvre d’Hellencourt, Julia Regazzini Spinardi, Lu Wang, Moe H. Kyaw
Comparison of Three Devices Preventing Skin Damage During Facial Mask Ventilation in Acute Respiratory Failure: Multicenter Randomized Controlled Trial Protocol (3PROSNIVtrial)
Raffaele Scala, Federica Andolfi, Giulia Ottaviano, Teresa Renda, Elena Ceparano, Manuela Caneschi, Luca Guidelli, Maria Laura Vega, Lara Pisani, Ilaria Bassi, Alfredo Aprile, Stefania Bertini, Daniela Bonanni, Patrizia Zoccali, Michele Vitacca, Luca Barbano, María Torrano Ferrández, Ana Rozúa López, Genoveva Ruiz Villa, Santino A. Marchese, Geraldine Lo Grasso, Elisabetta Fiandra, Elvio Scoscia, Amir Eslami, Emanuela Albo, Stefano Baglioni, Nicola Facciolongo, Claudia Castagnetti, Chiara Barbieri, Fabio Boccafoglio, Sonia Viola, Antonio M. Esquinas
Frequently asked questions
How long does it take to publish?
2-week peer review, 3-4 weeks from acceptance to online, and median submission to first decision of 2 days.
Reformat to Pulmonary Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is referenced for submissions claiming a 20% discount on the Rapid Service Fee for original research relating to previously published study protocols.
Reformat to Pulmonary Therapy using Livewrite PremiumWhat are the publication costs?
Mandatory Rapid Service Fee of £5120/€5950/$7675 upon acceptance. Additional fee applies for podcast articles.
Reformat to Pulmonary Therapy using Livewrite Premium